|

Atezolizumab 1200 mg Clinical Trials

1 actively recruiting trial

Also known as: Tecentriq®

Pipeline

Phase 2: 1

Top Sponsors

  • Centre Leon Berard1

Indications

  • Metastatic Gastrointestinal Stromal Tumor1
  • Locally Advanced Gastrointestinal Stromal Tumor (GIST)1
  • Unresectable Gastrointestinal Stromal Tumor (GIST)1
  • Cancer1

Other1 trial

A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.